13FPulse
中
CB

CBLL CERIBELL INC

2026Q2 · CUSIP 15678C102 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
122
Institutions that reported holding it to the SEC
Net increase in holders
+1
Last quarter 121 → now 122
How unusual is that
Below average
Stronger than only 41% of US stocks
What the filings say, in one paragraph

122 funds held CBLL at the end of 2026Q2, up 1 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $102M(YoY +31.7%), return on equity is -51.4%. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2025Q1: holders=86 2025Q2: holders=95 2025Q3: holders=99 2025Q4: holders=116 2026Q1: holders=121 2026Q2: holders=122 -17 -8.5 +0 +8.5 +17 77103129 25Q125Q225Q325Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush

This stock has never had a buying rush

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
68
Change in large funds
+5
Total value they hold
$593M
Funds buying for the first time
18
Funds that sold out entirely
17
Price change that quarter
+49.6%
Funds holding puts (bearish)
0
Funds holding calls (bullish)
0

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.75
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+31.7%
Net margin
-64.7%
ROE
-51.4%
Debt ratio
22.9%
FCF (TTM)
-$55M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2025-03-31: EPS -0.36 2025-06-30: EPS -0.38 2025-09-30: EPS -0.37 2025-12-31: EPS -0.35 2026-03-31: EPS -0.52 2026-06-30: EPS -0.51 0M 14M 28M $M -0.57 -0.29 0.00 202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-19M-10M0K 202420252026
Latest quarter $-19M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.